dapsone has been researched along with Granulomatosis, Orofacial in 1 studies
Granulomatosis, Orofacial: A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kemmler, N | 1 |
| Pfannschmidt, N | 1 |
| Strohal, R | 1 |
1 other study available for dapsone and Granulomatosis, Orofacial
| Article | Year |
|---|---|
Orofacial granulomatosis as first manifestation of Crohn's disease: successful treatment of both conditions with a combination of infliximab and dapsone.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Biopsy; Colonoscopy; Crohn Disease; Da | 2012 |